As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $4.90, up 4.03% from its previous closing price of $4.71. On the day, 1467256 shares were traded.
Ratios:
To gain a deeper understanding of ALHC’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Underweight rating and assigned the stock a target price of $4.50.
On March 06, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On January 24, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $11.Stifel initiated its Buy rating on January 24, 2024, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 ’24 when Maroney Dawn Christine sold 10,151 shares for $4.84 per share. The transaction valued at 49,131 led to the insider holds 1,976,097 shares of the business.
Kardes Hakan sold 4,363 shares of ALHC for $21,117 on Mar 28 ’24. The Chief Experience Officer now owns 430,444 shares after completing the transaction at $4.84 per share. On Mar 28 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,299 shares for $4.84 each. As a result, the insider received 20,807 and left with 865,407 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.51 while its Price-to-Book (P/B) ratio in mrq is 5.90.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $9.20, while it has fallen to a 52-week low of $4.46.
Shares Statistics:
A total of 188.95M shares are outstanding, with a floating share count of 89.93M. Insiders hold about 52.41% of the company’s shares, while institutions hold 43.06% stake in the company.
Earnings Estimates
As of right now, 11 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.22 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.25, while EPS last year was -$0.2. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.06 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.3 and -$0.75 for the fiscal current year, implying an average EPS of -$0.58. EPS for the following year is -$0.47, with 11 analysts recommending between -$0.21 and -$0.59.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $596.38M. It ranges from a high estimate of $598.56M to a low estimate of $594.88M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $439.15M, an estimated increase of 35.80% from the year-ago figure. For the next quarter, 10 analysts are estimating revenue of $606.85M, an increase of 38.20% over than the figure of $35.80% in the same quarter last year. There is a high estimate of $620.26M for the next quarter, whereas the lowest estimate is $586.4M.
A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $2.43B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.4B. In the same quarter a year ago, actual revenue was $1.82B, up 31.60% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $2.88B in the next fiscal year. The high estimate is $3.04B and the low estimate is $2.75B. The average revenue growth estimate for next year is up 20.00% from the average revenue estimate for this year.
